Biotech · Private company
Arthrosi Therapeutics
Track this companyFree. Adds Arthrosi Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials71 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- AR882 50 mgPhase 3 · GoutClinicalTrials.gov · fetched Nov 12, 2026
- AR882 75 mgPhase 3 · GoutClinicalTrials.gov · fetched Nov 12, 2026
- Allopurinol TabletPhase 2 · GoutClinicalTrials.gov · fetched Nov 12, 2026
- AR882 Dose 1Phase 2 · GoutClinicalTrials.gov · fetched Nov 12, 2026
- AR882 Dose 2Phase 2 · GoutClinicalTrials.gov · fetched Nov 12, 2026
- XOI High DosePhase 2 · GoutClinicalTrials.gov · fetched Nov 12, 2026
- XOI Low DosePhase 2 · GoutClinicalTrials.gov · fetched Nov 12, 2026
- [14C]AR882Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- AR882 Multiple DosePhase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- AR882 Single DosePhase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed PatientsPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 3, 2025ClinicalTrials.gov NCT07116746 · fetched Nov 12, 2026
- Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)PHASE3 · COMPLETED · started Mar 11, 2025ClinicalTrials.gov NCT06846515 · fetched Nov 12, 2026
- Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)PHASE3 · COMPLETED · started Jun 26, 2024ClinicalTrials.gov NCT06439602 · fetched Nov 12, 2026
- Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous GoutPHASE2 · COMPLETED · started Aug 12, 2022ClinicalTrials.gov NCT05253833 · fetched Nov 12, 2026
- Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout PatientsPHASE2 · COMPLETED · started Nov 16, 2021ClinicalTrials.gov NCT05119686 · fetched Nov 12, 2026
- Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal ImpairmentPHASE1 · COMPLETED · started Jan 14, 2021ClinicalTrials.gov NCT04646889 · fetched Nov 12, 2026
- Single-dose AME Study With [14C]AR882 in Healthy Male SubjectsPHASE1 · COMPLETED · started Jul 16, 2020ClinicalTrials.gov NCT04508426 · fetched Nov 12, 2026